TITLE

Editors' Picks

PUB. DATE
October 2008
SOURCE
Journal of Investigative Dermatology;Oct2008, Vol. 128 Issue 10, p2351
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article offers news briefs on dermatology. Pegylation of IFN-α2b has been observed to be an effective option for adjuvant treatment for melanoma. A study of integrin-αvβ3 has shown that it is an attractive target for the delivery of cancer therapeutics via nanoparticles. A study on systemic sclerosis in mice has shown that CD19 is critical in the disease.
ACCESSION #
34251505

 

Related Articles

  • IL-15/IL-15Rα intracellular trafficking in human melanoma cells and signal transduction through the IL-15Rα. Pereno, Raffaele; Giron-Michel, Julien; Gaggero, Alessia; Cazes, Eric; Meazza, Raffaella; Monetti, Monia; Monaco, Eugenia; Mishal, Zohar; Jasmin, Claude; Indiveri, Francesco; Ferrini, Silvano; Azzarone, Bruno // Oncogene;10/26/2000, Vol. 19 Issue 45, p5153 

    There are two IL-15 isoforms and eight isoforms for the IL-15Rα chain whose biological role is poorly understood. Here, we have analysed the intracellular trafficking of IL-15 and IL-15Rα and tried to shed some light on their function(s). In IL-15/GFP CHO transfectants both IL-15 isoforms...

  • The Therapeutic Potential of ADAM15. Lucas, Neali; Najy, Abdo J.; Day, Mark L. // Current Pharmaceutical Design;7/11/2009, Vol. 15 Issue 20, p2311 

    ADAM15 is a widely expressed multi-domain protease that has been implicated in the pathogenesis of many human diseases. Given the diversity of the ADAM15 functional domains, this protease is thought to affect several important cellular processes, including cell adhesion, degradation of...

  • Integrin αvβ6 sets the stage for colorectal cancer metastasis. Cantor, D.; Cheruku, H.; Nice, E.; Baker, M. // Cancer & Metastasis Reviews;Dec2015, Vol. 34 Issue 4, p715 

    The β6 subunit of the αvβ6 integrin heterodimer has long been an enigma in cancer biology though recent research has provided many new insights into its biology. Collectively, these findings include discovery of the transcriptional, translational and cell biological mechanisms by which...

  • Inflammatory signaling compromises cell responses to interferon alpha. HuangFu, W-C; Qian, J; Liu, C; Liu, J; Lokshin, A E; Baker, D P; Rui, H; Fuchs, S Y // Oncogene;1/12/2012, Vol. 31 Issue 2, p161 

    Interferon alpha (IFNα) is widely used for treatment of melanoma and certain other malignancies. This cytokine as well as the related IFNβ exerts potent anti-tumorigenic effects; however, their efficacy in patients is often suboptimal. Here, we report that inflammatory signaling impedes...

  • The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer. Schwartz, J. L.; Shajahan, A. N.; Clarke, R. // International Journal of Breast Cancer;2011, p1 

    Resistance to endocrine therapy is common among breast cancer patients with estrogen receptor alpha-positive (ER+) tumors and limits the success of this therapeutic strategy. While the mechanisms that regulate endocrine responsiveness and cell fate are not fully understood, interferon regulatory...

  • Activation of Notch1 signaling in stromal fibroblasts inhibits melanoma growth by upregulating WISP-1. Shao, H; Cai, L; Grichnik, J M; Livingstone, A S; Velazquez, O C; Liu, Z-J // Oncogene;10/20/2011, Vol. 30 Issue 42, p4316 

    The tumor microenvironment is emerging as an important target for cancer therapy. Fibroblasts (Fbs) within the tumor stroma are critically involved in promoting tumor growth and angiogenesis through secretion of soluble factors, synthesis of extracellular matrix and direct cell-cell interaction....

  • In melanoma, beta-catenin is a suppressor of invasion. Arozarena, I; Bischof, H; Gilby, D; Belloni, B; Dummer, R; Wellbrock, C // Oncogene;11/10/2011, Vol. 30 Issue 45, p4531 

    Cell-type-specific signalling determines cell fate under physiological conditions, but it is increasingly apparent that also in cancer development the impact of any given oncogenic pathway on the individual cancer pathology is dependent on cell-lineage-specific molecular traits. For instance in...

  • The Curcumin Analog EF24 Targets NF-κB and miRNA-21, and Has Potent Anticancer Activity In Vitro and In Vivo. Yang, Chuan He; Yue, Junming; Sims, Michelle; Pfeffer, Lawrence M. // PLoS ONE;Aug2013, Vol. 8 Issue 8, p1 

    EF24 is a curcumin analog that has improved anticancer activity over curcumin, but its therapeutic potential and mechanism of action is unknown, which is important to address as curcumin targets multiple signaling pathways. EF24 inhibits the NF-κB but not the JAK-STAT signaling pathway in...

  • Osteopontin signaling upregulates cyclooxygenase-2 expression in tumor-associated macrophages leading to enhanced angiogenesis and melanoma growth via α9β1 integrin. Kale, S; Raja, R; Thorat, D; Soundararajan, G; Patil, T V; Kundu, G C // Oncogene;5/1/2014, Vol. 33 Issue 18, p2295 

    Tumor-associated macrophages (TAMs) have multifaceted roles in tumor development, particularly linked with tumor angiogenesis and invasion, but the molecular mechanism underlying this association remains unclear. In this study, we report that lack of osteopontin (OPN) suppresses melanoma growth...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics